Recently, B7-H3 has been reported to promote cancer metastasis in patients with higher levels of B7-H3 expression, including gastric cancer [20], prostate cancer [21], pancreatic cancer [22], glioma [23] and colorectal cancer [24]. Here, CD276 is linked to prostate cancer.